Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma
| Autor: | Soussain, Carole, Issa, Samar *, Lewis, Katharine L, Grommes, Christian, Fox, Judith, Ward, Renee *, Peterson, Caryn *, Cravets, Matt *, Mathias, Anita *, Sosa, Judith *, Kirby, Brian J *, Ding, Zhaoqing *, Yusuf, Isharat *, Rose, Mark J *, Steinberg, Marcos W *, Tun, Han W. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:12068-12069 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|